Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The human
IFI 16
gene encodes a nuclear protein whose expression is associated with activation and differentiation of cells of the myeloid lineage, and which has recently been postulated to be a frequent target of human autoantibodies. We have used a unique monoclonal antibody in immunofluorescence studies to define the intranuclear distribution of
IFI 16
antigen in primary human leukocyte sub-populations. We demonstrate that
IFI 16
is expressed both within the nucleoli and nucleoplasm of mononuclear cells, but is not present in granulocytes.
IFI 16
expression correlated with that of the known nucleolar antigen B23, suggesting that the function of
IFI 16
is restricted to cells that have nucleoli and therefore are not terminally differentiated. These findings were supported by immunofluorescence studies in IFN-gamma-stimulated HL-60 cells and by biochemical fractionation of Daudi nuclear extract.
IFI 16
was extracted from whole nuclei at approximately 200-300 mM NaCl, within the range described for known transcription factors. Together with our previous findings, these results support a possible role of
IFI 16
in binding nucleic acid in vivo. Furthermore, a DNA-binding site was localized within a fusion protein containing the amino-terminal 159 amino acids. As the nucleic acid-binding domains of several proteins are targeted by autoantibodies in
SLE
, this region may be of significance in the pathogenesis of autoimmune disease.
...
PMID:The interferon-inducible autoantigen, IFI 16: localization to the nucleolus and identification of a DNA-binding domain. 754 91